摘要
肝损伤是临床常见的危害人类健康的疾病,是各种原因引起肝脏疾病的共同的表现,也是各型肝病共同的病理基础。建立稳定可靠体外肝细胞损伤模型,对于肝损伤病理机制研究及有效防治肝损伤药物筛选提供了前提。针对肝细胞损伤分子机制不同,目前已成功建立基于免疫损伤、氧化损伤、脂肪损伤等体外肝细胞损伤模型,用于临床药物筛选及疗效作用机制研究,本文对目前常见体外肝细胞损伤模型及其发生的分子生物学机制进行探讨。
Liver injury is a common clinical disease threatening people's health, it is a variety of liver diseases common performance and pathological basis. Establishing the stable model of hepatic cell injury in vitro provides the precondition for studying on the mechanism of liver injury and screening the drugs for prevention and treatment of liver injury. At present, hepatic cell injury models in vitro based on different molecular mechanisms such as immune injury, oxidative damage, fatty liver injury, have been successfully established, which applied for drugs screening and the mechanism of action of the drugs. This paper reviewed the common hepatic cell injury model in vitro at present and its molecular mechanisms.
出处
《现代生物医学进展》
CAS
2014年第9期1786-1789,共4页
Progress in Modern Biomedicine
基金
国家科技重大专项资助项目-基于转化医学的艾滋病
病毒性肝炎和结核病中医证侯生物学研究(2012ZX10005001)
国家自然科学基金资助项(81102720)
关键词
肝损伤
细胞模型
体外
机制
Liver injury
Cell model
In vitro
Mechanism